Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,977,067
-$3,597,598 QoQ
Shares Held
3,856,063
-2.5% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#26
of 639 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CIBC Bancorp USA Inc. holds $59,294,882 across 16 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (60.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
3,856,063 | $35,977,067 | |
| 2 | ZTS |
Zoetis Inc.
|
187,289 | $13,458,587 | |
| 3 | VTRS |
Viatris Inc
|
281,420 | $4,468,948 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,689 | $1,456,980 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
4,821 | $812,530 | |
| 6 | LQDA |
Liquidia Corp
|
7,835 | $624,683 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
5,516 | $611,944 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
14,332 | $496,889 |
All Filings in HLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,977,067 | 3,856,063 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $39,574,665 | 3,953,513 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||